Axa
LCTX icon

Axa’s Lineage Cell Therapeutics LCTX Stock Holding History

Axa’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,171,515
Closed -$1.15M – 1268
2019
Q3 		$1.15M Sell
1,171,515
-35,188
-3% -$36.4K ﹤0.01% 965
2019
Q2 		$1.33M Sell
1,206,703
-5,897
-0.5% -$6.8K 0.01% 919
2019
Q1 		$1.59M Hold
1,212,600
– – 0.01% 889
2018
Q4 		$1.11M Sell
1,212,600
-1,189,957
-50% -$1.82M ﹤0.01% 952
2018
Q3 		$4.94M Sell
2,402,557
-228,237
-9% -$479K 0.02% 677
2018
Q2 		$4.74M Buy
2,630,794
+15,866
+0.6% +$31.9K 0.02% 669
2018
Q1 		$6.15M Sell
2,614,928
-12,464
-0.5% -$29.2K 0.02% 591
2017
Q4 		$4.94M Buy
+2,627,392
New +$5.74M 0.02% 655

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return